Molecular Assemblies Announces the Appointment of Two Industry Leaders to Its Commercial-Technology Advisory Board | PR Newswire [Video]

• Board member, Todd C. Peterson, Ph.D., serves as Chair of the CTAB
• New appointments include David Smoller, Ph.D., serial entrepreneur and General Partner at Cultivation Capital Life Sciences and Stephen Turner, Ph.D., Founder at PacBio

, /PRNewswire/ — Molecular Assemblies, Inc., (“MAI” or the “Company”) a pioneer in the field of enzymatic DNA synthesis, today announced the addition of two industry leaders to its Commercial-Technology Advisory Board (CTAB), which includes experts in the commercialization of nucleic acid technologies and innovative life science product solutions. The CTAB provides strategic guidance on the Company’s commercialization strategies for Molecular Assemblies’ Fully Enzymatic Synthesis™ (FES™ technology, which accelerates the production of long, pure, and accurate DNA to power the next generation of therapeutics, diagnostics, agricultural products, and industrial materials.

“With the deep knowledge, wisdom, and experience commercializing transformative life science products, the CTAB enables Molecular Assemblies to identify emerging opportunities and trends in the life sciences industry that can be solved …